期刊文献+

载脂蛋白E基因与中国汉族阿尔茨海默病发病年龄的相关性 被引量:3

Correlation between Apolipoprotein E polymorphism and age at onset of Alzheimer's disease in a Chinese Han population
原文传递
导出
摘要 目的探讨载脂蛋白E基因多态性和中国汉族阿尔茨海默病(AD)患者发病年龄的相关性。方法研究对象来源于北京协和医院认知障碍门诊1999--2010年连续就诊的495例很可能AD患者,根据发病年龄分为早发性AD(EOAD,发病年龄〈65岁)和晚发性AD(LOAD,发病年龄≥65岁)。应用聚合酶链反应-限制性片段长度多态性分析法检测ApoE基因型。应用单因素方差分析不同基因型和AD发病年龄的相关性,应用一般线性模型分析AD患者发病年龄的影响因素。结果495例AD发病年龄为(69±10)岁,其中149例EOAD的发病年龄为(58±5)岁,而346例LOAD的发病年龄为(74±6)岁。不同的ApoE基因型与早发性AD患者发病年龄无统计学相关性[ε4-/-:(57±5)岁,n=90;ε4+/-:(59±5)岁,n=50;ε4+/+:(59±5)岁,n=9;F=0.99,P=0.38],而携带ApoEε4的基因型与晚发性AD患者的发病年龄存在统计学相关性[ε4-/-:(75±6)岁,n=189;ε4+/-:(73±6)岁,n=138;ε4+/+:(71±5)岁,n=19;F=6.51,P=0.002]。晚发性AD患者中,5种基因型发病年龄总体比较差异有统计学意义,发病年龄从大到小依次是ε2/3〉ε3/3〉ε3/4〉ε2/4〉ε4/4。在LOAD患者中,无痴呆家族史者不同基因型发病年龄差异有统计学意义(F=5.18,P〈0.01),而有痴呆家族史者不同基因型发病年龄差异无统计学意义(F=1.73,P〉0.05)。结论携带ε4的ApoE基因型可能降低了中国汉族晚发性AD患者发病年龄,呈现ε4剂量依赖效应。而在具有痴呆家族史患者中未观察到这种效应。 Objective To investigate the correlation between the ApoE genotype and age at onset in a cohort of hospital- based AD patients of Han population in China. Methods All cases were consecutive probable AD patients from the Memory and Cognitive Impairment Clinic of Peking Union Medical Collge Hospital from 1999 to 2010. They were all Han ethnicity. They were divided into two groups according to age at onset(AAO) : early onset AD ( EOAD, AAO 〈 65 years) and late onset AD (LOAD, AAO 〉165 years). DNA was extracted and ApoE was genotyped by polymerase chain reaction-restriction fragment length polymorphism analysis. The linkage between ApoE polymorphism and AAO of AD were analyzed by one-way ANOVA. Results AAO of all cases(n =495) was (69±10) years,of EOAD(n = 149) was (58 ±5)years and of LOAD ( n = 346) was (74± 6) years. ApoEε4 ( + ) genotypes were not associated with AAO of EOAD [ε4-/- :(57 ±5) years,n=90;ε4 +/- :(59 ±5) years,n =50;ε4 +/+ :(59±5) years,n =9;F = 0. 99 ,P =0. 38] ,while they were significantly associated with AAO of LOAD[ ε4 -/- : ( 75 ±6) years, n =189; ε4 +/- :(73±6) years,n = 138;ε4 +/+ :(71±5) years,n=19;F=6.51,P=0. 0021. As for all ApoE genotypes, AAO of LOAD reduced gradually in a way as follows : ε2/3 〉 ε3/3 〉 ε3/4 〉 ε2/4 〉 ε4/ 4. There was great correlation between AAO and ApoE polymorphism in LOAD without dementia family history,whereas no correlation in LOAD with dementia family history. Conclusion ApoE genotypes carrying at least oneε4 allele maybe significantly lower AAO of LOAD in a dose-dependent manner whereas no such correlation in LOAD with dementia family history.
出处 《中华医学杂志》 CAS CSCD 北大核心 2013年第3期182-186,共5页 National Medical Journal of China
关键词 阿尔茨海默病 载脂蛋白E 基因多态性 发病年龄 Alzheimer's disease Apolipoprotein E Gene polymorphism Age at onset
  • 相关文献

参考文献19

  • 1Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's diseasein late onset families. Science, 1993, 261:921-923.
  • 2Raber J, Huang Y, Ashford JW. ApoE genotype accounts for the vast majority of AD risk and AD pathology. Neurobiol Aging, 2004, 25:641-650.
  • 3Farrer LA, Cupples LA, Haines JL, et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA, 1997, 278: 1349- 1356.
  • 4McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer' s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology, 1984, 34:939-944.
  • 5Dubois B, Feldman I-IH, Jacova C, et al. Research criteria for the diagnosis of Alzheimer' s disease: revising the NINCDS- ADRDA criteria. Lancet Neurol, 2007, 6:734-746.
  • 6郭峰,张振馨,许群,张俊武,赵华路.载脂蛋白E ε4和ε2等位基因与胎儿宫内发育的关系[J].中华神经科杂志,2008,41(12):835-839. 被引量:3
  • 7Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hhal. J Lipid Res, 1990, 31:545-548.
  • 8van der Flier WM, Pijnenburg YA, Fox NC, et al. Early-onset versus late-onset Alzheimer's disease: the case of the missing APOE e4 allele. Lancet Neurol, 2011, 10:280-288.
  • 9Munoz DG, Feldman H. Causes of Alzheimer's disease. CMAJ, 2000, 162:65-72.
  • 10Davidson Y, Gibbons L, Pritchard A, et al. Apolipoprotein E epsilon4 allele frequency and age at onset of Alzheimer's disease. Dement Geriatr Cogn Disord, 2007, 23:60-66.

二级参考文献17

  • 1江三多,冯国鄞,吴晓东,林嗣萃,顾牛范,金通观,康伟民,高哲石,任大明,江开达.Alzheimer病与载脂蛋白E ε_4等位基因的关联分析[J].中华精神科杂志,1996,29(1):15-18. 被引量:39
  • 2Zhang TS Wang HQ Wang WY He YS Huang SK.Relationship between apolipoprotein E, D10S1225 polymorphisms and late-onset Alzheimer's disease[J].中国生物学文摘,2006,20(8):16-16. 被引量:1
  • 3马玉梅,张振馨.APOE基因多态性与阿尔茨海默病关系研究的进展[J].基础医学与临床,2007,27(7):739-744. 被引量:5
  • 4Barker DJ. In utero programming of chronic disease. Clin Sci (Lond) , 1998, 95: 115-128.
  • 5Tideman E, Marsdl K, Ley D. Cognitive function in young adults following intrauterine growth restriction with abnormal fetal aortic blood flow. Ultrasound Obstet Gynecol, 2007, 29: 614-618.
  • 6Heinonen K, Raikkonen K, Pesonen AK, et al. Prenatal and postnatal growth and cognitive abilities at 56 months of age: a longitudinal study of infants born at term. Pediatrics, 2008, 121: e1325-e1333.
  • 7Martyn CN, Gale CR, Sayer AA, et al. Growth in utero and cognitive function in adult life: follow up study of people born between 1920 and 1943. BMJ, 1996, 312: 1393-1396.
  • 8Gale CR, Walton S, Martyn CN. Foetal and postnatal head growth and risk of cognitive decline in old age. Brain, 2003, 126 Pt 10: 2273 -2278.
  • 9Richards M, Hardy R, Kuh D, et al. Birth weight and cognitive function in the British 1946 birth cohort: longitudinal population based study. BMJ, 2001, 322: 199-203.
  • 10Tong S, Baghurst P, McMichael A. Birthweight and cognitive development during childhood. J Paediatr Child Health, 2006, 42 : 98-103.

共引文献13

同被引文献34

  • 1王峰,徐娉,朱思慧,张士亮,屠楠.枣庄市区老年痴呆知晓率及流行病学调查[J].中国实用神经疾病杂志,2010,13(23):9-11. 被引量:30
  • 2中国防治认知功能障碍专家共识专家组.中国防治认知功能障碍专家共识[J].中华内科杂志,2006,45(2):171-173. 被引量:592
  • 3Alzheimer's Association. 2014 Alzheimer's disease facts and figures[J]. Alzheimers Dement, 2014, ]0(2): e47-92.
  • 4Bekris LM, Yu CE, Bird TD, et al. Genetics of Alzheimer disease[J]. J Geriatr Psychiatry Neurol, 2010, 23(4) : 213-227.
  • 5Brickell KL, Steinbart EJ, Rumbaugh M, et al. Early-onset Alzheimer disease in families with late-onset Alzheimer disease: a potential important subtype of familial Alzheimer disease[J]. Arch Neurol, 2006, 63(9): 1307-1311.
  • 6Campion D, Dumanehin C, Hannequin D, et al. Early-onset autosomal dominant Alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrum[J]. Am J Hum Genet, 1999, 65(3): 664-670.
  • 7Kivipelto M, Helkala EL, Laakso MP, et al. Apolipoprotein E epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease[J]. Ann Intern Med, 2002, 137(3) : 149-155.
  • 8Lleo A, Blesa R, Queralt R, et al. Frequency of mutations in the presenilin and amyloid precursor protein genes in early-onset A|zheimer disease in Spain[J]. Arch Neurol, 2002, 59 (11): 1759-1763.
  • 9Rogaeva EA, Fafel KC, Song YQ, et al. Screening for PSI mutations in a referral-based series of AD cases: 21 novel mutations[J]. Neurology, 2001, 57(4): 621-625.
  • 10Zekanowski C, Styczynska M, Peplonska B, et al. Mutations in presenilin I, presenilin 2 and amyloid precursor protein genes in patients with early-onset Alzheimer's disease in Poland[J]. Exp Neurol, Z003, 184(2): 991-996.

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部